Douglas Emmett (DEI)
(Delayed Data from NYSE)
$13.37 USD
+0.06 (0.45%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $13.38 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Douglas Emmett (DEI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$13.63 | $16.00 | $9.00 | 2.40% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Douglas Emmett comes to $13.63. The forecasts range from a low of $9.00 to a high of $16.00. The average price target represents an increase of 2.4% from the last closing price of $13.31.
Analyst Price Targets (12)
Broker Rating
Douglas Emmett currently has an average brokerage recommendation (ABR) of 2.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 2.86 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 14.29% and 7.14% of all recommendations. A month ago, Strong Buy made up 14.29%, while Buy represented 7.14%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 9 | 9 | 9 | 9 | 9 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/22/2024 | Piper Sandler | Alexander Goldfarb | Hold | Hold |
2/7/2024 | Scotiabank | Nicholas Yulico | Hold | Hold |
2/1/2024 | BMO Capital Markets | John P Kim | Strong Sell | Strong Sell |
1/7/2024 | BTIG | Thomas W Catherwood | Not Available | Hold |
11/10/2023 | Raymond James | William A Crow | Moderate Buy | Moderate Buy |
10/3/2023 | Wedbush Securities | Richard Anderson | Hold | Hold |
9/12/2023 | KeyBanc Capital Markets | Upal D Rana | Hold | Hold |
8/17/2023 | Evercore Partners | Stephen Sakwa | Hold | Hold |
8/1/2023 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.86 |
ABR (Last week) | 2.86 |
# of Recs in ABR | 14 |
Average Target Price | $13.63 |
LT Growth Rate | NA |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 156 of 252 |
Current Quarter EPS Est: | 0.43 |